User profiles for Ravikiran Vedururu

Ravikiran vedururu

Medical Scientist, Molecular Pathology, Peter MacCallum Cancer Centre
Verified email at petermac.org
Cited by 3870

Whole–genome characterization of chemoresistant ovarian cancer

…, PJ Wilson, J Ellul, O McNally, MA Doyle, R Vedururu… - Nature, 2015 - nature.com
Patients with high-grade serous ovarian cancer (HGSC) have experienced little
improvement in overall survival, and standard treatment has not advanced beyond platinum-based …

[HTML][HTML] Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing

SQ Wong, J Li, AYC Tan, R Vedururu, JMB Pang… - BMC medical …, 2014 - Springer
Background Clinical specimens undergoing diagnostic molecular pathology testing are fixed
in formalin due to the necessity for detailed morphological assessment. However, formalin …

[HTML][HTML] Circulating tumour DNA reflects treatment response and clonal evolution in chronic lymphocytic leukaemia

…, YC Chan, SQ Wong, MJ Silva, R Vedururu… - Nature …, 2017 - nature.com
Several novel therapeutics are poised to change the natural history of chronic lymphocytic
leukaemia (CLL) and the increasing use of these therapies has highlighted limitations of …

[HTML][HTML] Zika vector transmission risk in temperate Australia: a vector competence study

JB Duchemin, PT Mee, SE Lynch, R Vedururu… - Virology journal, 2017 - Springer
Background Zika virus is an emerging pathogen of global importance. It has been responsible
for recent outbreaks in the Americas and in the Pacific region. This study assessed five …

Molecular disease monitoring using circulating tumor DNA in myelodysplastic syndromes

…, SQ Wong, R Agarwal, R Vedururu… - Blood, The Journal …, 2017 - ashpublications.org
The diagnosis and monitoring of myelodysplastic syndromes (MDSs) are highly reliant on
bone marrow morphology, which is associated with substantial interobserver variability. …

[HTML][HTML] Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer

…, AP Fellowes, GM Arnau, T Kader, R Vedururu… - Modern Pathology, 2017 - Elsevier
The spectrum of genomic alterations in ductal carcinoma in situ (DCIS) is relatively
unexplored, but is likely to provide useful insights into its biology, its progression to invasive …

[HTML][HTML] Assessing the clinical value of targeted massively parallel sequencing in a longitudinal, prospective population-based study of cancer patients

…, K Doig, J Ellul, TJ Bosma, D Irwin, R Vedururu… - British journal of …, 2015 - nature.com
Methods: Cancer 2015 study is a large-scale, prospective, multisite cohort of newly diagnosed
cancer patients from Victoria, Australia with 1094 patients recruited. MPS was performed …

Mosaicism in tuberous sclerosis complex: Lowering the threshold for clinical reporting

…, M Wallis, X Gao, L Sun, J Wu, R Vedururu… - Human …, 2022 - Wiley Online Library
Tuberous sclerosis complex (TSC) is a multi‐system genetic disorder. Most patients have
germline mutations in TSC1 or TSC2 but, 10%–15% patients do not have TSC1/TSC2 …

[HTML][HTML] PathOS: a decision support system for reporting high throughput sequencing of cancers in clinical diagnostic laboratories

…, ER Thompson, A Kumar, L Lara, R Vedururu… - Genome medicine, 2017 - Springer
Background The increasing affordability of DNA sequencing has allowed it to be widely
deployed in pathology laboratories. However, this has exposed many issues with the analysis …

[HTML][HTML] RNASeq Analysis of Aedes albopictus Mosquito Midguts after Chikungunya Virus Infection

RK Vedururu, MJ Neave, M Tachedjian, MJ Klein… - Viruses, 2019 - mdpi.com
Chikungunya virus (CHIKV) is an emerging pathogen around the world and causes significant
morbidity in patients. A single amino acid mutation in the envelope protein of CHIKV has …